Abstract

Cardiothoracic surgery using cardiopulmonary bypass (CPB) triggers an inflammatory state that may be difficult to differentiate from infection. Heparin-binding protein (HBP) is a candidate biomarker for sepsis. As data indicates that HBP normalizes rapidly after cardiothoracic surgery, it may be a suitable early marker of postoperative infection. We therefore aimed to investigate which variables influence postoperative HBP levels and whether elevated HBP concentration is associated with poor surgical outcome. This exploratory, prospective, observational study enrolled 1475 patients undergoing cardiothoracic surgery using CPB, where HBP was measured at ICU arrival. Patients with HBP in the highest tercile were compared to remaining patients. Multivariable logistic regressions were performed to identify factors predictive of elevated HBP and 30-day mortality. Overall median HBP was 30.0 ng/mL. Patients undergoing isolated CABG or surgery with CPB-duration ≤ 60 min had a median HBP of 24.9 ng/mL and 23.2 ng/mL, respectively. Independent predictors of elevated postoperative HBP included increased EuroSCORE, prolonged CPB-duration and high intraoperative temperature. Increased HBP was an independent predictor of 30-day mortality. This study confirms the promising characteristics of HBP as a biomarker for identification of postoperative sepsis, especially after routine procedures. Further studies are required to investigate whether HBP may detect postoperative infections.

Details

Title
Utility of heparin-binding protein following cardiothoracic surgery using cardiopulmonary bypass
Author
Johannesson, Emilia 1 ; Erixon, Clara 1 ; Sterner, Niklas 1 ; Thelaus, Louise 2 ; Dardashti, Alain 1 ; Nilsson, Johan 3   VIAFID ORCID Logo  ; Ragnarsson, Sigurdur 1 ; Linder, Adam 2 ; Zindovic, Igor 1 

 Lund University, Skane University Hospital, Department of Cardiothoracic Surgery, Clinical Sciences, Lund, Sweden (GRID:grid.411843.b) (ISNI:0000 0004 0623 9987) 
 Lund University, Division of Infection Medicine, Department of Clinical Sciences Lund, Faculty of Medicine, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361) 
 Lund University, Thoracic Surgery and Bioinformatic Research Unit, Department of Translational Medicine, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361); Skảne University Hospital, Department of Thoracic and Vascular Surgery, Lund, Sweden (GRID:grid.411843.b) (ISNI:0000 0004 0623 9987) 
Pages
21566
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2898790849
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.